Investigation of Hepatitis B and Hepatitis C in Taiwan - Full Text View

Sponsor:	National Taiwan University Hospital
Information provided by:	National Taiwan University Hospital
ClinicalTrials.gov Identifier:	NCT00946010

Purpose

The purpose of this study is to investigate the differences of genotypes of hepatitis B and hepatitis C in Taiwan.

Condition	Intervention
Hepatitis B Hepatitis C	Biological: blood sampling and abdominal sonography

Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Cross-Sectional
Official Title:	Investigation of Hepatitis B and Hepatitis C in Taiwan

Resource links provided by NLM:

MedlinePlus related topics: Hepatitis Hepatitis A Hepatitis B Hepatitis C Ultrasound

Drug Information available for: Recombinant Hepatitis B vaccine Hepatitis A Vaccines

U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:

genotype and DNA level or RNA level of HBV and HCV virus [ Time Frame: once during Mar. 2008- Jan. 2011 ] [ Designated as safety issue: No ]

Biospecimen Retention: Samples With DNA

10ml blood was sampled and then serum was be retained.

Enrollment:	6228
Study Start Date:	April 2008
Study Completion Date:	January 2011
Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
1 Click here for more information about this study: Investigation of Hepatitis B and Hepatitis C in Taiwan	Biological: blood sampling and abdominal sonography 10cc blood sampling and abdominal sonography Other Name: 10cc blood sampling and abdominal sonography

Detailed Description:

The purpose of this study is investigating the differences of genotypes and DNA level or RNA level of hepatitis B and hepatitis C in Taiwan.

Eligibility

Ages Eligible for Study:	23 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

People Born before 1985/01/01 who live in Taiwan are HBV or HCV pateints.

Criteria

Inclusion Criteria:

Born before 1985/01/01
HBV or HCV carriers

Exclusion Criteria:

N/A

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00946010

Locations

Taiwan
National Taiwan University Hospital
Taipei, Taiwan, 100

Sponsors and Collaborators

National Taiwan University Hospital

Investigators

Study Chair:

Jin-Chuan Sheu, M.D. P.H.D.

National Taiwan University Hospital

More Information

No publications provided

Responsible Party:	National Taiwan University Hospital
ClinicalTrials.gov Identifier:	NCT00946010 History of Changes
Other Study ID Numbers:	200801059R
Study First Received:	April 1, 2008
Last Updated:	January 20, 2011
Health Authority:	Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:

Hepatitis B
Hepatitis C
genotype

DNA level
RNA level
Taiwan

Additional relevant MeSH terms:

Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human

Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Hepadnaviridae Infections
DNA Virus Infections
Flaviviridae Infections

ClinicalTrials.gov processed this record on May 23, 2012